Introduction: Retroperitoneal liposarcomas are unusual tumors. Their biological and clinical features different from other retroperitoneal sarcomas.
Aim: To analyze our series of retroperitoneal liposarcomas.
Patients And Methods: Retrospective study of 10 patients with retroperitoneal liposarcoma diagnosed in the last 16 years at our institution. Symptoms, diagnosis, treatment and prognosis were analyzed.
Results: Radical resection was done in all cases. Postoperative mortality was 10%. Complementary treatment was considered in each patient. Recurrent disease occurred in 8 patients (14 recurrences), during follow up. In 42% of them recurrences were resected. Actuarial 5-year survival rate was 44%.
Conclusion: Poor prognosis of retroperitoneal liposarcoma is due to its high recurrence rate.
Download full-text PDF |
Source |
---|
ANZ J Surg
March 2025
Division of Cancer Surgery, Peter MacCallum Cancer Centre, and Sir Peter MaCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
Purpose: Retroperitoneal sarcomas (RPS) present a surgical challenge due to their complex anatomical relationships to organs and vascular structures. In this limited case series, we reconstructed the tumour beds of four cases of RPS and their ex vivo specimens.
Methods: Four patients underwent surgical resection of their retroperitoneal sarcoma at our centre in 2023-2024.
Indian J Otolaryngol Head Neck Surg
February 2025
Oral and Maxillofacial Surgery, Hi-Tech Dental College and Hospital, Bhubaneswar, Odisha India.
Dedifferentiated liposarcoma (DDLPS) is a nonlipogenic sarcoma arising in association with well-differentiated liposarcoma (LPS), and represents 10% of liposarcomas. Most of the cases of dedifferentiated liposarcoma arise in the retroperitoneal region, followed by deep soft tissue of the extremities, trunk, mediastinum, spermatic cord, and the head and neck region. We report a case of a 35 year old male patient who had DDLPS of the left parotid gland.
View Article and Find Full Text PDFCancer Med
March 2025
Department of Surgery, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Background: The role of preoperative inflammatory markers in predicting postoperative outcomes has been investigated in different types of cancer. However, little is known about retroperitoneal sarcoma (RPS). This study aimed to evaluate the association between preoperative inflammatory status and major postoperative morbidity in patients undergoing RPS surgery.
View Article and Find Full Text PDFAnn Surg Oncol
February 2025
Sarcoma Service, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Ann Surg Oncol
February 2025
Sarcoma Service, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!